FDBusiness.com

Epax, the leading Omega-3 concentrates company, will be demonstrating its unparalleled expertise on stand 16040 at this year’s Vitafoods exhibition in Geneva, taking place on 14 – 16 May.

Epax is the world’s leading B2B supplier of premium, highly concentrated marine-derived EPA/DHA Omega-3 oils to the global dietary supplement industry.  Its clinically proven top-quality formulas are developed with various EPA/DHA concentrations and ratios to target specific health conditions and it is this aspect which the company will focus on at Vitafoods 2013.

Speaking at the Supplier Seminar Theatre on 14 May at 14.35, Epax’s Scientific Advisor Dr. Morten Bryhn, a specialist in cardiology and internal medicine, will speak about ‘Inflammation – A Three Step Process Mediated by PUFAs’.  Ongoing inflammation is often associated with sustained elevations of chemical mediators of inflammation, known as pro-inflammatory biomarkers.  Dr. Bryhn will discuss the various mechanisms by which polyunsaturated fatty acids (PUFAs) affect these biomarkers.

Epax has a long, distinguished history of marine oil production.  The company is dedicated to constantly endeavouring to improve the purity, quality, and innovation of its product portfolio, as well as the proprietary production and purification technologies it uses in its manufacturing process.  Epax products are manufactured to pharma quality control standards.

This enables Epax to set its own production specifications which are beyond established regulations and as a result, Epax is constantly setting new purity and quality standards for the industry.  Epax has also recently updated its product specifications with even lower maximum values for environmental pollutants and in fact Epax even beats its own standards with up to 60-90% in relation to actual average production values. 

Traceability is also a crucial factor in Omega-3 oil manufacturing and the company prides itself on being able to trace the oil from the moment the fish is caught through the entire manufacturing process. Traceability is the prerequisite for sustainability and Epax is committed to only sourcing fish oil from sources certified by independent 3rd parties.  Because of its unique position in the Omega-3 marketplace, Epax also maintains a consistent and constant stock of crude oil and can offer continuous supply security to meet customer demand.

On the innovation side, Epax has invested significantly in next generation large-scale SMB concentrates for ultra-high concentrates, which will be manufactured at the new UK  facility. This is currently in development and products will be commercialized Q3 this year.